-
1
A multimodal integrative approach to model transcriptional addiction of thyroid cancer on RUNX2
Published 2022-09-01Get full text
Article -
2
Adding pieces to the puzzle of differentiated-to-anaplastic thyroid cancer evolution: the oncogene E2F7
Published 2023-02-01Get full text
Article -
3
Ex vivo mapping of enhancer networks that define the transcriptional program driving melanoma metastasis
Published 2023-12-01Get full text
Article -
4
-
5
CSNK1A1, KDM2A, and LTB4R2 Are New Druggable Vulnerabilities in Lung Cancer
Published 2021-07-01Get full text
Article -
6
OVOL2 impairs RHO GTPase signaling to restrain mitosis and aggressiveness of Anaplastic Thyroid Cancer
Published 2022-03-01Get full text
Article -
7
An Innovative Drug Repurposing Approach to Restrain Endometrial Cancer Metastatization
Published 2023-03-01Get full text
Article -
8
BET inhibitors drive Natural Killer activation in non-small cell lung cancer via BRD4 and SMAD3
Published 2024-03-01Get full text
Article -
9
-
10
-
11
No Need to Stick Together to Be Connected: Multiple Types of Enhancers’ Networking
Published 2021-10-01Get full text
Article -
12
Inhibition of BET Proteins and Histone Deacetylase (HDACs): Crossing Roads in Cancer Therapy
Published 2019-03-01Get full text
Article -
13
Molecular Fingerprints of Malignant Pleural Mesothelioma: Not Just a Matter of Genetic Alterations
Published 2021-06-01Get full text
Article -
14
Endogenous Extracellular Matrix Regulates the Response of Osteosarcoma 3D Spheroids to Doxorubicin
Published 2023-02-01Get full text
Article -
15
-
16
-
17
-
18
-
19
-
20
Mutational Profile of Malignant Pleural Mesothelioma (MPM) in the Phase II RAMES Study
Published 2020-10-01Get full text
Article